- Home
- ILMN vs EXPE Comparison
ILMN vs EXPE Comparison
Compare ILMN & EXPE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ILMN
- EXPE
- Stock Information
- Founded
- ILMN 1998
- EXPE 1996
- Country
- ILMN United States
- EXPE United States
- Employees
- ILMN N/A
- EXPE N/A
- Industry
- ILMN Medical Specialities
- EXPE Transportation Services
- Sector
- ILMN Health Care
- EXPE Consumer Discretionary
- Exchange
- ILMN Nasdaq
- EXPE Nasdaq
- Market Cap
- ILMN 23.1B
- EXPE 22.4B
- IPO Year
- ILMN 2000
- EXPE 1999
- Fundamental
- Price
- ILMN $135.05
- EXPE $181.35
- Analyst Decision
- ILMN Buy
- EXPE Buy
- Analyst Count
- ILMN 20
- EXPE 28
- Target Price
- ILMN $160.68
- EXPE $160.32
- AVG Volume (30 Days)
- ILMN 2.0M
- EXPE 1.7M
- Earning Date
- ILMN 11-04-2024
- EXPE 11-07-2024
- Dividend Yield
- ILMN N/A
- EXPE N/A
- EPS Growth
- ILMN N/A
- EXPE 39.78
- EPS
- ILMN N/A
- EXPE 7.63
- Revenue
- ILMN $4,390,000,000.00
- EXPE $13,394,000,000.00
- Revenue This Year
- ILMN N/A
- EXPE $8.43
- Revenue Next Year
- ILMN $4.00
- EXPE $7.25
- P/E Ratio
- ILMN N/A
- EXPE $23.77
- Revenue Growth
- ILMN N/A
- EXPE 6.56
- 52 Week Low
- ILMN $90.17
- EXPE $107.25
- 52 Week High
- ILMN $156.66
- EXPE $190.40
- Technical
- Relative Strength Index (RSI)
- ILMN 37.03
- EXPE 72.56
- Support Level
- ILMN $149.05
- EXPE $179.11
- Resistance Level
- ILMN $156.66
- EXPE $183.66
- Average True Range (ATR)
- ILMN 5.17
- EXPE 5.10
- MACD
- ILMN -1.85
- EXPE 1.24
- Stochastic Oscillator
- ILMN 7.01
- EXPE 75.14
About ILMN Illumina Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2023 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
About EXPE Expedia Group Inc.
Expedia is the world's second-largest online travel agency by bookings, offering services for lodging (80% of total 2023 sales), air tickets (3%), rental cars, cruises, in-destination, and other (11%), and advertising revenue (6%). Expedia operates a number of branded travel booking sites, but its three core online travel agency brands are Expedia, Hotels.com, and Vrbo. It also has a metasearch brand, Trivago. Transaction fees for online bookings account for the bulk of sales and profits.